317 related articles for article (PubMed ID: 23337836)
1. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
Roldán V; Marín F; Fernández H; Manzano-Fernández S; Gallego P; Valdés M; Vicente V; Lip GY
Am J Cardiol; 2013 Apr; 111(8):1159-64. PubMed ID: 23337836
[TBL] [Abstract][Full Text] [Related]
2. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
4. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.
Guo Y; Wang H; Zhao X; Zhang Y; Zhang D; Ma J; Wang Y; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4678-84. PubMed ID: 23972369
[TBL] [Abstract][Full Text] [Related]
5. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY
J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209
[TBL] [Abstract][Full Text] [Related]
6. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
Lip GY; Frison L; Halperin JL; Lane DA
J Am Coll Cardiol; 2011 Jan; 57(2):173-80. PubMed ID: 21111555
[TBL] [Abstract][Full Text] [Related]
7. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
10. Renal dysfunction and atrial fibrillation recurrence following cardioversion.
Schmidt M; Daccarett M; Rittger H; Marschang H; Holzmann S; Jung P; Bojanic D; Ketteler M; Brachmann J; Rieber J
J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1092-8. PubMed ID: 21489032
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
Jover E; Roldán V; Gallego P; Hernández-Romero D; Valdés M; Vicente V; Lip GY; Marín F
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):627-33. PubMed ID: 22609214
[TBL] [Abstract][Full Text] [Related]
12. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality.
Tsagalis G; Akrivos T; Alevizaki M; Manios E; Stamatellopoulos K; Laggouranis A; Vemmos KN
Nephrol Dial Transplant; 2009 Jan; 24(1):194-200. PubMed ID: 18728156
[TBL] [Abstract][Full Text] [Related]
13. Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 - 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study.
Chiu PF; Huang CH; Liou HH; Wu CL; Chang C; Chang CC; Chang HR
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):504-8. PubMed ID: 24755133
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
[TBL] [Abstract][Full Text] [Related]
15. Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
Wieloch M; Jönsson KM; Själander A; Lip GY; Eriksson N; Svensson PJ
Thromb Res; 2013 Jun; 131(6):481-6. PubMed ID: 23351664
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
17. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
[TBL] [Abstract][Full Text] [Related]
18. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis.
Abdelhafiz AH; Myint MP; Tayek JA; Wheeldon NM
Clin Ther; 2009 Jul; 31(7):1534-9. PubMed ID: 19695402
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
